In a prevention trial of lenacapavir, an existing anti-HIV drug, there were zero infections. Infectious diseases expert Roger Shapiro says it could be a game-changer.
Insurance coverage disruptions, challenges accessing care, common for Medicaid enrollees after expiration of COVID-era coverage protections, study finds
Researchers designed a “linear urban forest” and plan to quantify its climate- and health-related benefits for U.S. cities, using Springfield, Mass., as a pilot